Lexeo Therapeutics (LXEO): An Undervalued Leader in Cardiac Gene TherapyAt the heart of the matter...Back of the Napkin BiosAug 02, 2025∙ Paid12ShareThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign in